Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

LUCD

Lucid Diagnostics (LUCD)

Lucid Diagnostics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:LUCD
DateTimeSourceHeadlineSymbolCompany
11/03/202500:01PR Newswire (US)Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on March 24, 2025NASDAQ:LUCDLucid Diagnostics Inc
06/03/202508:45PR Newswire (US)Lucid Diagnostics Announces Closing of $15.3 Million Registered Direct OfferingNASDAQ:LUCDLucid Diagnostics Inc
06/03/202508:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LUCDLucid Diagnostics Inc
05/03/202522:36Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:LUCDLucid Diagnostics Inc
05/03/202500:25PR Newswire (US)Lucid Diagnostics Announces $15.3 Million Registered Direct OfferingNASDAQ:LUCDLucid Diagnostics Inc
05/03/202500:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LUCDLucid Diagnostics Inc
04/03/202523:56Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LUCDLucid Diagnostics Inc
28/02/202500:31PR Newswire (US)Renowned Investigators Awarded $8 Million NIH Grant to Study Lucid Diagnostics' EsoGuard® in At-Risk Patients without Symptomatic GERDNASDAQ:LUCDLucid Diagnostics Inc
26/02/202500:31PR Newswire (US)Lucid Diagnostics Regains Compliance with Nasdaq Minimum Bid Price RequirementNASDAQ:LUCDLucid Diagnostics Inc
22/02/202509:56Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LUCDLucid Diagnostics Inc
22/02/202508:58Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LUCDLucid Diagnostics Inc
22/02/202508:46Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LUCDLucid Diagnostics Inc
21/02/202500:31PR Newswire (US)Lucid Diagnostics Executes First Concierge Medicine Contract with LEAA HealthNASDAQ:LUCDLucid Diagnostics Inc
19/02/202500:30PR Newswire (US)PAVmed Regains Compliance with Nasdaq Stockholders' Equity RequirementNASDAQ:LUCDLucid Diagnostics Inc
14/02/202505:38Edgar (US Regulatory)Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:LUCDLucid Diagnostics Inc
07/02/202500:57PR Newswire (US)Lucid Diagnostics to Participate in the 12th Annual BTIG MedTech, Digital Health, Life Science & Diagnostic Tools ConferenceNASDAQ:LUCDLucid Diagnostics Inc
01/02/202508:49Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:LUCDLucid Diagnostics Inc
01/02/202508:46Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:LUCDLucid Diagnostics Inc
13/01/202523:56PR Newswire (US)Lucid Diagnostics Announces Record Quarterly EsoGuard® Test VolumeNASDAQ:LUCDLucid Diagnostics Inc
24/12/202400:01PR Newswire (US)Lucid Diagnostics Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price RuleNASDAQ:LUCDLucid Diagnostics Inc
21/12/202408:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LUCDLucid Diagnostics Inc
20/12/202400:01PR Newswire (US)Lucid Diagnostics Partners with VITALExam to Enhance Esophageal Precancer Detection for FirefightersNASDAQ:LUCDLucid Diagnostics Inc
12/12/202400:01PR Newswire (US)Prospective Clinical Utility Study of Lucid Diagnostics' EsoGuard® Esophageal DNA Test Accepted for Peer-Reviewed PublicationNASDAQ:LUCDLucid Diagnostics Inc
07/12/202408:10Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:LUCDLucid Diagnostics Inc
04/12/202400:01PR Newswire (US)Lucid Diagnostics Completes Convertible Debt Refinancing to Strengthen Balance Sheet and Extend Cash Runway Past Key Near-Term MilestonesNASDAQ:LUCDLucid Diagnostics Inc
30/11/202408:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LUCDLucid Diagnostics Inc
20/11/202423:56PR Newswire (US)Lucid Diagnostics Submits Clinical Evidence Package to MolDX Seeking Medicare Coverage for EsoGuard® Esophageal DNA TestNASDAQ:LUCDLucid Diagnostics Inc
19/11/202409:27Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LUCDLucid Diagnostics Inc
19/11/202400:15PR Newswire (US)Lucid Diagnostics to Present at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services ForumNASDAQ:LUCDLucid Diagnostics Inc
15/11/202400:01PR Newswire (US)PAVmed Provides Business Update and Third Quarter 2024 Financial ResultsNASDAQ:LUCDLucid Diagnostics Inc
 Showing the most relevant articles for your search:NASDAQ:LUCD